vs

Side-by-side financial comparison of CAPRICOR THERAPEUTICS, INC. (CAPR) and La Rosa Holdings Corp. (LRHC). Click either name above to swap in a different company.

La Rosa Holdings Corp. is the larger business by last-quarter revenue ($20.2M vs $11.1M, roughly 1.8× CAPRICOR THERAPEUTICS, INC.). La Rosa Holdings Corp. runs the higher net margin — -27.4% vs -63.9%, a 36.6% gap on every dollar of revenue. On growth, La Rosa Holdings Corp. posted the faster year-over-year revenue change (3.2% vs -7.9%). Over the past eight quarters, CAPRICOR THERAPEUTICS, INC.'s revenue compounded faster (93.0% CAGR vs 72.5%).

Capricor Therapeutics is a clinical-stage biotechnology company focused on discovering, developing and commercializing innovative biological therapies including cell and gene therapies for rare diseases, cardiovascular disorders and muscular conditions. It primarily operates in the U.S. market, addressing unmet medical needs for patient groups with limited treatment options.

V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.

CAPR vs LRHC — Head-to-Head

Bigger by revenue
LRHC
LRHC
1.8× larger
LRHC
$20.2M
$11.1M
CAPR
Growing faster (revenue YoY)
LRHC
LRHC
+11.1% gap
LRHC
3.2%
-7.9%
CAPR
Higher net margin
LRHC
LRHC
36.6% more per $
LRHC
-27.4%
-63.9%
CAPR
Faster 2-yr revenue CAGR
CAPR
CAPR
Annualised
CAPR
93.0%
72.5%
LRHC

Income Statement — Q4 FY2024 vs Q3 FY2025

Metric
CAPR
CAPR
LRHC
LRHC
Revenue
$11.1M
$20.2M
Net Profit
$-7.1M
$-5.5M
Gross Margin
8.4%
Operating Margin
-69.1%
-24.7%
Net Margin
-63.9%
-27.4%
Revenue YoY
-7.9%
3.2%
Net Profit YoY
-833.8%
-125.7%
EPS (diluted)
$-0.11
$-5.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAPR
CAPR
LRHC
LRHC
Q3 25
$20.2M
Q2 25
$23.2M
Q1 25
$17.5M
Q4 24
$11.1M
$17.7M
Q3 24
$2.3M
$19.6M
Q2 24
$4.0M
$19.1M
Q1 24
$4.9M
$13.1M
Q4 23
$12.1M
Net Profit
CAPR
CAPR
LRHC
LRHC
Q3 25
$-5.5M
Q2 25
$78.4M
Q1 25
$-95.7M
Q4 24
$-7.1M
$-5.1M
Q3 24
$-12.6M
$-2.5M
Q2 24
$-11.0M
$-2.3M
Q1 24
$-9.8M
$-4.6M
Q4 23
$-762.1K
Gross Margin
CAPR
CAPR
LRHC
LRHC
Q3 25
8.4%
Q2 25
8.0%
Q1 25
8.8%
Q4 24
8.9%
Q3 24
8.3%
Q2 24
8.3%
Q1 24
8.9%
Q4 23
Operating Margin
CAPR
CAPR
LRHC
LRHC
Q3 25
-24.7%
Q2 25
-10.6%
Q1 25
-26.7%
Q4 24
-69.1%
-17.1%
Q3 24
-575.2%
-8.9%
Q2 24
-291.9%
-9.7%
Q1 24
-209.2%
-35.0%
Q4 23
-10.6%
Net Margin
CAPR
CAPR
LRHC
LRHC
Q3 25
-27.4%
Q2 25
337.8%
Q1 25
-546.5%
Q4 24
-63.9%
-28.7%
Q3 24
-555.2%
-12.5%
Q2 24
-277.0%
-12.2%
Q1 24
-199.6%
-35.1%
Q4 23
-6.3%
EPS (diluted)
CAPR
CAPR
LRHC
LRHC
Q3 25
$-5.44
Q2 25
$15.25
Q1 25
$-5.86
Q4 24
$-0.11
$28.54
Q3 24
$-0.38
$-16.49
Q2 24
$-0.35
$-12.49
Q1 24
$-0.31
$-0.35
Q4 23
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAPR
CAPR
LRHC
LRHC
Cash + ST InvestmentsLiquidity on hand
$151.5M
$4.0M
Total DebtLower is stronger
$642.8K
Stockholders' EquityBook value
$145.5M
$1.6M
Total Assets
$170.5M
$21.7M
Debt / EquityLower = less leverage
0.41×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAPR
CAPR
LRHC
LRHC
Q3 25
$4.0M
Q2 25
$5.1M
Q1 25
$2.9M
Q4 24
$151.5M
$1.4M
Q3 24
$85.0M
$1.8M
Q2 24
$29.5M
$1.6M
Q1 24
$39.9M
$1.1M
Q4 23
$39.5M
Total Debt
CAPR
CAPR
LRHC
LRHC
Q3 25
$642.8K
Q2 25
$644.3K
Q1 25
$645.9K
Q4 24
$647.6K
Q3 24
$649.2K
Q2 24
$650.8K
Q1 24
$652.4K
Q4 23
Stockholders' Equity
CAPR
CAPR
LRHC
LRHC
Q3 25
$1.6M
Q2 25
$3.4M
Q1 25
$-87.5M
Q4 24
$145.5M
$2.6M
Q3 24
$68.3M
$5.0M
Q2 24
$11.5M
$4.7M
Q1 24
$18.4M
$5.6M
Q4 23
$22.6M
Total Assets
CAPR
CAPR
LRHC
LRHC
Q3 25
$21.7M
Q2 25
$22.9M
Q1 25
$21.0M
Q4 24
$170.5M
$19.4M
Q3 24
$93.0M
$19.7M
Q2 24
$38.3M
$18.7M
Q1 24
$49.4M
$16.3M
Q4 23
$58.7M
Debt / Equity
CAPR
CAPR
LRHC
LRHC
Q3 25
0.41×
Q2 25
0.19×
Q1 25
Q4 24
0.25×
Q3 24
0.13×
Q2 24
0.14×
Q1 24
0.12×
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAPR
CAPR
LRHC
LRHC
Operating Cash FlowLast quarter
$-14.8M
$-1.3M
Free Cash FlowOCF − Capex
$-15.3M
FCF MarginFCF / Revenue
-137.3%
Capex IntensityCapex / Revenue
4.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAPR
CAPR
LRHC
LRHC
Q3 25
$-1.3M
Q2 25
$-1.4M
Q1 25
$-3.5M
Q4 24
$-14.8M
$-1.1M
Q3 24
$-11.6M
$-591.6K
Q2 24
$-12.3M
$-803.1K
Q1 24
$-1.3M
$-538.3K
Q4 23
$-11.6M
Free Cash Flow
CAPR
CAPR
LRHC
LRHC
Q3 25
Q2 25
Q1 25
Q4 24
$-15.3M
Q3 24
$-11.7M
Q2 24
$-12.3M
Q1 24
$-1.9M
Q4 23
$-12.2M
FCF Margin
CAPR
CAPR
LRHC
LRHC
Q3 25
Q2 25
Q1 25
Q4 24
-137.3%
Q3 24
-515.2%
Q2 24
-310.9%
Q1 24
-38.3%
Q4 23
-100.5%
Capex Intensity
CAPR
CAPR
LRHC
LRHC
Q3 25
Q2 25
Q1 25
Q4 24
4.4%
Q3 24
0.4%
Q2 24
1.5%
Q1 24
12.4%
Q4 23
4.6%
Cash Conversion
CAPR
CAPR
LRHC
LRHC
Q3 25
Q2 25
-0.02×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAPR
CAPR

Segment breakdown not available.

LRHC
LRHC

Real Estate Residential Brokerage Services$16.8M83%
Transferred Over Time$3.5M17%

Related Comparisons